Consistently, our findings revealed that in a thyroid carcinoma cell model with BRAF V600E genetic background, the upregulation of RAC1 activity is able to potentiate the positive impact on NIS expression induced by MEK inhibition. This evidence concerns the gene BRAF and thyroid gland carcinoma.